Neximmune to announce third quarter 2021 financial results and provide corporate update on november 12, 2021

Gaithersburg, md., nov. 08, 2021 (globe newswire) -- neximmune, inc. (nasdaq: nexi), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific t cells, today announced it plans to report third quarter financial results and provide a corporate update on friday, november 12, 2021, via press release, prior to the market open.
NEXI Ratings Summary
NEXI Quant Ranking